Massachusetts Financial Services’s Vir Biotechnology VIR Stock Holding History

Massachusetts Financial Services’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$902K	Buy	+88,507	New	+$842K	﹤0.01%	899
2023 Q4	–	Sell	-63,057	Closed	-$591K	–	872
2023 Q3	$591K	Sell	63,057 -2,417	-4%	-$34.5K	﹤0.01%	797
2023 Q2	$1.61M	Sell	65,474 -1,542	-2%	-$38.7K	﹤0.01%	724
2023 Q1	$1.56M	Sell	67,016 -39,948	-37%	-$1.02M	﹤0.01%	726
2022 Q4	$2.71M	Buy	106,964 +2,257	+2%	+$55.3K	﹤0.01%	700
2022 Q3	$2.02M	Sell	104,707 -958	-0.9%	-$24.4K	﹤0.01%	725
2022 Q2	$2.69M	Buy	105,665 +537	+0.5%	+$12.5K	﹤0.01%	691
2022 Q1	$2.7M	Buy	+105,128	New	+$3.12M	﹤0.01%	721
2021 Q2	–	Sell	-20,152	Closed	-$1.03M	–	942
2021 Q1	$1.03M	Sell	20,152 -33,335	-62%	-$1.8M	﹤0.01%	832
2020 Q4	$1.43M	Buy	53,487 +17,741	+50%	+$577K	﹤0.01%	771
2020 Q3	$1.23M	Buy	+35,746	New	+$1.54M	﹤0.01%	761

Other funds holding VIR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GSK plc London $602M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Massachusetts Financial Services's VIR Position: Q2 2026 in Review

Massachusetts Financial Services opened a new position in Vir Biotechnology (VIR) in Q2 2026: 88,507 shares worth $902K. The stake represents ﹤0.01% of the portfolio and ranks #899 among its holdings. This is a return to the name: Massachusetts Financial Services previously reported a position in VIR as recently as Q3 2023.

Massachusetts Financial Services first reported a position in VIR in Q3 2020 and has held it in 11 quarters since. The position peaked at $2.71M in Q4 2022. 238 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

Massachusetts Financial Services held 88,507 shares of Vir Biotechnology worth $902K as of Q2 2026.
Vir Biotechnology was a new Massachusetts Financial Services position in Q2 2026.
Vir Biotechnology made up ﹤0.01% of Massachusetts Financial Services's portfolio in Q2 2026, its #899 holding.
Massachusetts Financial Services first reported a position in Vir Biotechnology in Q3 2020 and has held it in 11 quarters since.
Massachusetts Financial Services's Vir Biotechnology position peaked at $2.71M in Q4 2022.
238 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Massachusetts Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.